Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

ETR/2X1 stock hub

ETR/2X1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/2X1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.4B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/2X1

In the news

Latest news · ETR/2X1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-135.6

P25 n/aP50 n/aP75 n/a

ROIC-48.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/2X1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

EUR

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	69
Employees Change	5%
Employees Change Percent	8.06
Enterprise value	EUR 7.9B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 8.4B
Price	EUR 105
Price currency	EUR
Rev Per Employee	66,231.88x
Sic	2836
Symbol	etr/2X1
Website	https://www.abivax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.02%
EV Earnings	-23.37x
EV/FCF	-48.71x
FCF yield	-1.93%
P/B ratio	18.35x
P/S ratio	1,828.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 4.6M
Gross Profit Growth	-63.22%
Gross Profit Growth Q	-55.37%
Gross Profit Growth3 Y	0.48%
Net Income	EUR -336.1M
Pretax Margin	-7,226.56%
Profit Per Employee	EUR -4.9M
ROA	-38.95
Roa5y	-37.56
ROCE	-47.2
ROE	-135.6
Roe5y	-198.1
ROIC	-48.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	-63.22x
Revenue Growth Q	-55.37x
Revenue Growth3 Y	0.48x
Revenue Growth5 Y	218.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 584.3M
Cash	EUR 530.4M
Current Assets	EUR 551.2M
Current Liabilities	EUR 63M
Debt	EUR 32.1M
Debt Equity	EUR 0.07
Debt FCF	EUR -0.2
Equity	EUR 455.2M
Interest Coverage	-8.64
Liabilities	EUR 129.1M
Long Term Assets	EUR 33.1M
Long Term Liabilities	EUR 66.1M
Net Cash	EUR 498.3M
Net Cash By Market Cap	EUR 5.96
Net Cash Growth	1,318.05%
Net Debt Equity	EUR -1.09
Tangible Book Value	EUR 430.2M
Tangible Book Value Per Share	EUR 5.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.75
Net Working Capital	EUR -40.9M
Quick ratio	8.58
Working Capital	EUR 488.2M
Working Capital Turnover	EUR 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	100.6
All Time High	132.2
All Time High Change	-20.57%
All Time High Date	2026-01-12
All Time Low	68.1
All Time Low Change	54.19%
All Time Low Date	2025-09-18
ATR	4.2
Ch YTD	-12.94
High	105
High52	132.2
High52 Date	2026-01-12
High52ch	-20.57%
Low	105
Low52	68.1
Low52 Date	2025-09-18
Low52ch	54.19%
Ma50ch	4.42%
RSI	55.96
RSI Monthly	0
RSI Weekly	56.67
Sharpe ratio	1.12x
Sortino ratio	1.88
Total Return	-10.28%
Tr YTD	-12.94
Tr1m	5%
Tr1w	5.37%
Tr3m	8.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -246.1M
Operating margin	-5,384.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,135,279%
Net Borrowing	-59,533,000
Shares Insiders	0.63%
Shares Institutions	98.84%
Shares Qo Q	7.21%
Shares Yo Y	10.28%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -196.7M
Average Volume	2,000.7x
Bv Per Share	5.8
CAPEX	EUR -142,000
Ch1m	5
Ch1w	5.37
Ch3m	8.03
Ch6m	18.51
Change	-1.96%
Change From Open	0
Close	107.1
Days Gap	-1.96
Depreciation Amortization	1,072,000
Earnings Date	2026-05-25
EBIT	EUR -246.1M
EBITDA	EUR -245M
EPS	EUR -4.83
F Score	3
FCF	EUR -161.3M
FCF EV Yield	-2.05x
Financing CF	547,307,000
Fiscal Year End	December
Founded	2,013
Goodwill	18,419,000
Income Tax	EUR 5.8M
Investing CF	-8,193,000
Is Primary Listing	0
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Ma150	97.58
Ma150ch	7.6%
Ma20	101.4
Ma20ch	3.57%
Net CF	372,464,000
Next Earnings Date	2026-05-25
Open	105
Ppne	2,090,000
Price Date	2026-05-08
Ptbv Ratio	19.42
Relative Volume	0.94x
Revenue	4,570,000x
SBC By Revenue	774.55x
Share Based Comp	35,397,000
Tax By Revenue	127.96x
Tr6m	18.51%
Volume	0
Z Score	11.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/2X1 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ETR/2X1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.8%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.3%

Negative means the company is buying back shares.

Technical

ETR/2X1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.0

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/2X1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/2X1 stock rating?

etr/2X1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/2X1 analysis?

The full report lives at /stocks/etr/2X1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/2X1?

The latest report frames etr/2X1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/2X1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.